Teva Reports Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Teva Pharma (TEVA) PT Lowered to $14 at Susquehanna
November 6, 2017 7:25 AM ESTSusquehanna lowered its price target on Teva Pharma (NYSE: TEVA) to $14.00 (from $20.00) while maintaining a Positive rating.
Analyst Andrew Finkelstein notes Q3 showed further challenges.
... MoreTeva Pharma (TEVA) PT Slashed to $10 at Cantor Fitzgerald
November 2, 2017 1:39 PM EDTCantor Fitzgerald analyst Louise Chen lowered her price target on Teva Pharma (NYSE: TEVA) to $10.00 (from $17.00) while maintaining a Neutral rating following Q3 miss and lower guide.
Chen thinks the company has some meaningful headwinds which need to be addressed before the... More
Teva Pharma (TEVA) Plunges to Fresh Low, Down 16%
November 2, 2017 9:33 AM EDTTeva Pharma (NYSE: TEVA) Plunges to Fresh Low, Down 16%
... More